These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 11515306

  • 1. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M, Polónia J, Brandão F, Ramalhão C, da Faria DB.
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [Abstract] [Full Text] [Related]

  • 2. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
    Cerqueira-Gomes M, Polónia J, Brandão F, Ramalhão C, de Faria DB.
    Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635
    [Abstract] [Full Text] [Related]

  • 3. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J, Cruz Fernández JM, de Teresa Galván E, Ferreira Montero IJ, López-Sendón J, Soler Soler J, Tamargo Menéndez J.
    Rev Esp Cardiol; 1996 May; 49(5):317-27. PubMed ID: 8744385
    [Abstract] [Full Text] [Related]

  • 4. [Neurohormonal assessment in heart failure: from the sophisticated laboratory to practical indications].
    Dei Cas L, Metra M, Visioli O.
    G Ital Cardiol; 1993 Feb; 23(2):193-204. PubMed ID: 8098306
    [Abstract] [Full Text] [Related]

  • 5. [Neurohumoral regulation in heart failure].
    Riegger GA, Muders F, Luchner A.
    Z Kardiol; 1996 Feb; 85 Suppl 6():205-10. PubMed ID: 9064967
    [Abstract] [Full Text] [Related]

  • 6. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K.
    Am J Cardiol; 2005 May 02; 95(9A):8B-13B. PubMed ID: 15847852
    [Abstract] [Full Text] [Related]

  • 7. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM, Lee FA.
    Cardiol Clin; 1995 Feb 02; 13(1):5-26. PubMed ID: 7796432
    [Abstract] [Full Text] [Related]

  • 8. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH.
    Circulation; 1990 Feb 02; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [Abstract] [Full Text] [Related]

  • 9. [Pathophysiology of congestive heart failure].
    Luzza F, Bruni F, Rizzo F, Carerj S.
    Minerva Cardioangiol; 2002 Jun 02; 50(3):209-19. PubMed ID: 12107401
    [Abstract] [Full Text] [Related]

  • 10. Hormones and hemodynamics in heart failure.
    Schrier RW, Abraham WT.
    N Engl J Med; 1999 Aug 19; 341(8):577-85. PubMed ID: 10451464
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
    Packer M.
    Circulation; 1988 Jun 19; 77(6 Pt 2):I64-73. PubMed ID: 2967129
    [Abstract] [Full Text] [Related]

  • 12. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A.
    Pharmacol Ther; 2004 Jun 19; 102(3):223-41. PubMed ID: 15246247
    [Abstract] [Full Text] [Related]

  • 13. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ.
    J Cardiovasc Pharmacol; 1986 Jun 19; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [Abstract] [Full Text] [Related]

  • 14. Neurohormonal activity in congestive heart failure.
    Kubo SH.
    Crit Care Med; 1990 Jan 19; 18(1 Pt 2):S39-44. PubMed ID: 2136721
    [Abstract] [Full Text] [Related]

  • 15. [The physiopathological aspects and new therapeutic approaches in cardiac-circulatory failure].
    Peruzzi G, Di Nardo P, Raimondi G, Legramante JM, Iellamo F, Massaro M, Bellegrandi F, Minieri M, Pafi M, Castrucci F.
    Clin Ter; 1992 Nov 19; 141(11):339-72. PubMed ID: 1493659
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiology and clinical spectrum of acute congestive heart failure.
    Shah M, Ali V, Lamba S, Abraham WT.
    Rev Cardiovasc Med; 2001 Nov 19; 2 Suppl 2():S2-6. PubMed ID: 12439355
    [Abstract] [Full Text] [Related]

  • 17. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS.
    Pharmacotherapy; 1993 Nov 19; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [Abstract] [Full Text] [Related]

  • 18. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K, Bleifeld W.
    Herz; 1990 Jun 19; 15(3):164-70. PubMed ID: 2198217
    [Abstract] [Full Text] [Related]

  • 19. Compensatory changes of sympathetic tone, the renin-angiotensin-aldosterone system, vasopressin, and ANF as potential therapeutic targets in congestive heart failure.
    van Zwieten PA.
    Z Kardiol; 1988 Jun 19; 77 Suppl 5():67-76. PubMed ID: 2975894
    [Abstract] [Full Text] [Related]

  • 20. [Renin, aldosterone and prostaglandins in heart failure].
    Riegger AJ.
    Z Kardiol; 1991 Jun 19; 80 Suppl 8():37-40. PubMed ID: 1796634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.